Company Profile
Year Established :
2018
Total Number of Staff :
100-500
Business Type :
Trading Company,Manufacturer
Main Sales Markets :
North America,Central/South America,Eastern Europe,Asia,Middle East,Africa
Product Range :
Oncology Products and General Injectables
Our Plant is WHO-cGMP Certified; state level GMP & GLP certified for the manufacture of a wide range of: Oncology products (Liquid and Lyophilized Injection, Tablets and Capsules) & General Injectables (Liquid & Lyophilized Injection and Pre filled syringes). Biozenta is working towards spearheading their presence globally.Our Facility has accreditation from regulatory bodies of: Kenya; Yemen, Iran PICS, Cambodia, Philippines & Malawi and awaiting site registration in Srilanka, Peru, Ethiopia, Syria, Tanzania, Nepal, and Iran.
Our dedicated regulatory team has filed for dossier registration in Myanmar, Costarica, Guatemala, Bolivia, Uzbekistan, Mongolia, Mexico, Ethiopia, Cuba, Nepal, Ecuador, Honduras, Vietnam, Tanzania, Kenya, and Algeria.